Clinical trial
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00003720 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00003720 |
|---|---|
| Title | SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma |
| Official title | A Multicenter, Dose Escalating Study in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | semaxanib |
| Start date | Jul 1, 1998 |
| First posted | Jun 16, 2004 |
| Last update posted | Aug 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: